Assessment of tissue viability has become an important issue in recent years. Scintigraphic measurements have provided important diagnostic, therapeutic, and prognostic infor mation in patients with myocardial dysfunction, who may improve in left ventricular function after revascularization. For detection of regional myocardial ischemia and viability, thallium 201 (201T1) has been the most widely used tracer in single-photon scintigraphy. However, 201T1 scintigraphy may underestimate regional viability, espe cially after myocardial infarction. Positron emission tomography (PET) provides an advanced imaging technology that permits the accurate definition of regional tracer distribution. In combination with nitrogen (13N) ammonia, PET allows for the sensitive and specific detection of coronary artery disease. Several studies indicate the superiority of this approach in comparison with standard 201T1 tomographic (SPECT) imaging. In addition, regional blood flow can be accurately measured with 13N ammonia PET, and this approach can be employed in conjunction with pharmacologic stress imaging to quantify regional flow reserve. In combination with metabolic markers, such as fluorine 18 (18F) deoxyglucose, an indicator of glucose uptake, PET is capable of assessing myocardial viability. Furthermore, the PET approach may differentiate between various forms of cardiomyopathy. More studies are needed to define the cost-benefit ratio of both the 201 T1 reinjection and the PET technique for the management of patients with coronary artery disease or cardiomyopathy.
Get full access to this article
View all access options for this article.
References
1.
Phelps ME, Mazziotta JC, Shelbert H.: Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart. New York: Raven Press, 1986.
2.
Yamashita K., Tamaki N., Yonekura Y., et al: Regional wall thickening of left ventricle evaluated by gated positron emission tomography in relation to myocardial perfusion and glucose metabolism. J Nucl Med32:679-685, 1991.
3.
Grover-McKay M., Schwaiger M., Krivokapich J., et al: Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy . J Am Coll Cardiol13:317-324, 1989.
4.
Niemeyer MG, Kuyper Afm, Gerhards LJ, et al: Nitrogen-13 ammonia perfusion imaging: Relation to metabolic imaging. Am Heart J125:848-854, 1993.
5.
Blanksma PK, Willemsen Atm, Meeder JG, et al: Quantitative myocardial mapping of perfusion and metabolism using parametric polar map displays in cardiac PET. J Nucl Med36:153-158, 1995.
6.
Meeder JG, Blanksma PK, Crijns Hjgm, et al: Mechanisms of angina pectoris in syndrome X assessed by myocardial perfusion dynamics and heart rate variability. Eur Heart J16:1571-1577, 1995.
7.
Walsh MN, Geltman EM, Brown MA, et al: Noninvasive estimation of regional myocardial oxygen consumption by positron emission tomography with carbon-1 acetate in patients with myocardial infarction. J Nucl Med30:1798-1808, 1989 .
8.
Armbrecht JJ , Buxton DB, Schelbert HR: Validation of 1[11c] acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium . Circulation81 :1594-1605, 1990 .
9.
Bonow RO, Dilsizian V.: Assessing viable myocardium with thallium-201. Am J Cardiol70:10E-17E, 1992.
10.
Nielsen AP, Morris KG, Murdock R., et al: Linear relationship between the distribution of thallium-201 and blood flow in ischemic and nonischemic myocardium during exercise. Circulation61:797-801, 1980.
11.
Melin JA, Becker LC: Quantitative relationship between global left ventricular thallium uptake and blood flow: Effects of propranolol, ouabain, dipyridamole, and coronary occlusion. J Nucl Med27 :641-652, 1986.
12.
Kuyper Afm, van Eck-Smit Blf, Niemeyer MG, et al: The role of scintigraphic techniques in the evaluation of functional results of coronary bypass grafting and percutaneous transluminal coronary angioplasty. Int J Card Imaging9:49-58, 1993.
13.
Beller GA, Gibson RS: Sensitivity, specificity and prognostic significance of noninvasive testing for occult or known coronary disease. Prog Cardiovasc Dis29:241-270, 1987.
14.
Wackers FJ, Fetterman R., Mattera JA, et al: Quantitative planar thallium-201 stress scintigraphy: A critical evaluation of the method. Semin Nucl Med15:46-66, 1985.
15.
Zijlstra F. , Fioretti P., Reiber JH, et al: Which cineangiographically assessed anatomic variable correlates best with functional measurements of stenosis severity ? A comparison of quantitative analysis of the coronary cineangiogram with measured coronary flow reserve and exercise/redistribution thallium-201 scintigraphy. J Am Coll Cardiol12:686-691, 1988.
16.
Pohost GM, Zir LM, Moore RH, et al: Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201Circulation55:294-302, 1977.
17.
Dilsizian V. , Bonow RO: Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation87:1-20, 1993.
18.
Cloninger KG , DePuey KG, Garcia EV, et al: Incomplete redistribution in delayed thallium-201 single photon emission computed tomographic (SPECT) images: An overestimation of myocardial scarring. J Am Coll Cardiol12:955-963, 1988.
19.
Kiat H., Berman DS, Maddahi J., et al: Late reversibility of tomographic myocardial thallium-201 defects: An accurate marker of myocardial viability. J Am Coll Cardiol12:1456-1463, 1988.
20.
Dilsizian V. , Rocco TP, Freedman Nmt, et al: Enhanced detection of ischemic but viable myocardium by reinjection of thallium after stress-redistribution imaging . N Engl J Med323:141-146, 1990.
21.
Dilsizian V. , Bonow RO: Differential uptake and apparent thallium-201 "washout" after thallium reinjection options regarding early redistribution imaging or late redistribution imaging after reinjection. Circulation85:1032-1038, 1992.
22.
Schroeder H. , Friedrich M., Topp H.: Myocardial viability ; what do we need? Eur J Nucl Med20:792-803, 1993.
23.
Dilsizian V. , Smeltzer WR, Freedman Nmt, et al: Thallium reinjection after stress-redistribution imaging. Does 24-hour delayed imaging after reinjection enhance detection of viable myocardium? Circulation83:1247-1255, 1991.
24.
van Eck-Smit Blf, van der Wall EE, Kuyper Afm, et al: Immediate thallium-201 reinjection following stress imaging: A time saving approach for detection of myocardial viability. J Nucl Med34:737-743, 1993.
25.
Shah A., Shelbert HR, Schwaiger M., et al: Measurement of regional myocardial blood flow with 13N ammonia and positron emission tomography in intact dogs. J Am Coll Cardiol5:92-100, 1985.
26.
Krivokapich J. , Smith GT, Huang S-C., et al: 13N ammonia myocardial imaging at rest and exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation80:1328-1337, 1989.
27.
Hutchins GD , Schwaiger M., Rosenspire KC, et al: Noninvasive quantification of regional blood flow in the human heart using 13N ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol15:1032-1042, 1990.
28.
Schelbert HR , Phelps ME, Huang SC, et al: 13N ammonia as an indicator of myocardial blood flow. Circulation63:1259-1272, 1981 .
29.
Rauch B., Helus F., Grunze M., et al: Kinetics of 13N ammonia uptake in myocardial single cells indicating potential limitations in its applicability as a marker of myocardial blood flow. Circulation71:387-393, 1985.
30.
Kambara H., Fudo T., Hashimoto T., et al: Silent myocardial ischemia in patients with myocardial infarction : Evaluation with positron emission computed tomography. Jpn Circ J53:1437-1443, 1989.
31.
Gould KL: Clinical cardiac positron emission tomography : State of the art. Circulation84[suppl I] :I-22-1-36, 1991.
32.
Schelbert HR , Wisenberg G., Phelps ME, et al: Noninvasive assessment of coronary stenosis by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in man with intravenous 13N ammonia and positron computed tomography. Am J Cardiol49:1197-1207, 1982.
33.
Yonekura Y. , Tamaki N., Senda M., et al: Detection of coronary artery disease with 13N ammonia and high resolution positron emission computed tomography . Am Heart J113:645-654, 1987.
34.
Zimmermann R., Tillmans H., Knapp WH, et al: Regional myocardial nitrogen-13 glutamate uptake in patients with coronary artery disease: Inverse post-stress relation to thallium 201 uptake in ischemia. J Am Coll Cardiol11:549-556, 1988.
35.
Gould KL: Percent coronary stenosis: Battered gold standard pernicious relic, or clinical practicality? J Am Coll Cardiol11:886-888, 1988.
36.
Schwaiger M. , Brunken RC, Krivokapich J., et al: Beneficial effect of residual anterograde flow on tissue viability as assessed by positron emission tomography in patients with myocardial infarction. Eur Heart J8:981-988, 1987.
37.
Brunken K., Schwaiger M., Grover-McKay M., et al: Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol10 :557-567, 1987.
38.
Marshall RC , Tillisch JH, Phelps ME, et al: Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography. 18F-labeled fluorodeoxyglucose and 13N ammonia. Circulation67:766-778, 1983.
39.
Williams BR : Positron emission tomography for the assessment of ischemia and myocardial viability. J Myocardial Ischemia2:33-64, 1990.
40.
Bonow RO, Dilsizian V., Cuocolo A., et al: Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose . Circulation83:26-37, 1991.
41.
Sobel BE, Geltman EM, Tiefenbrunn AJ, et al: Improvement of regional myocardial metabolism after coronary thrombolysis induced with tissue-type plasminogen activator or streptokinase . Circulation69:983-990, 1984.
42.
Goldstein RA , Kirkeeide R., Smalling RW, et al: Changes in myocardial perfusion reserve after PTCA: Noninvasive assessment with positron tomography. J Nucl Med28:1262-1267, 1987.
43.
Tillisch J. , Brunken R., Marschall R., et al: Reversibility of cardial wall-motion abnormalities predicted by positron tomography. N Engl J Med314:884-888, 1986.
44.
Demer LL, Gould KL, Goldstein R., et al: Noninvasive assessment of coronary collaterals in man by PET perfusion imaging. J Nucl Med31:259-270, 1990.
45.
Brunken K., Kottou S., Nienaber CA, et al: PET detection of viable tissue in myocardial segments with persistent defects at 201T1 SPECT. Radiology172:65-73, 1989.
46.
Schelbert HR : Positron emission tomography for the assessment of myocardial viability. Circulation84(suppl I):I-122-I-131, 1991.
47.
Vaghaiwalla-Mody FV, Brunken RC, Warner Stevenson L., et al: Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron tomography. J Am Coll Cardiol17:373-383, 1991.
48.
Geldman EM, Smith JL, Beecher D., et al: Altered regional myocardial metabolism in congestive cardiomyopathy detected by positron tomography. Am J Med74:773-785, 1983.
49.
Perloff JK, Roberts WC, Deleon Acj, et al: The distinctive electrocardiogram of Duchenne's progressive muscular dystrophy. An electrocardiographic pathologic correlative study. Am J Med42:179-188, 1967.
50.
Perloff JK, Henze E., Schelbert HR: Alterations in regional myocardial metabolism perfusion, and wall motion in Duchenne's muscular dystrophy studied by radionuclide imaging. Circulation69:33-42, 1984.
51.
Endo M., Yoshida K., Iinuma TA, et al: Noninvasive quantification of regional myocardial blood flow and ammonia extraction fraction using nitrogen-13 ammonia and positron emission tomography. Ann Nucl Med1:1-6, 1987.
52.
Yoshida K., Endo M., Himi T., et al: Measurement of regional myocardial blood flow in hypertrophic cardiomyopathy : Application of the first-pass flow model using 13N ammonia and PET. Am J Physiol Imaging4:97-104, 1989.
53.
Camici P., Chiriatti G., Lorenzoni R., et al: Coronary vasodilatation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: A study with nitrogen-13 ammonia and positron emission tomography. Am Coll Cardiol17:879-886, 1991.
54.
Kehtarnavaz N., Defigueiredo Rjp: A novel surface reconstruction and display method for cardiac PET imaging. IEEE Trans Medical ImagingMI-3:108-115, 1984.
55.
Posma JL, Blanksma PK, van de Wall EE, et al: Redistribution of myocardial perfusion during permanent dual chamber pacing in symptomatic nonobstructive hypertrophic cardiomyopathy: A quantitative positron emission tomography study. Heart75:511-513, 1996.
56.
Tamaki N., Ohtani H., Yamashita K., et al: Metabolic activity in the areas of new fill-in after thallium 201 reinjection: Comparison with positron emission tomography using fluorine-18-deoxyglucose . J Nucl Med32:673-678, 1991.
57.
Tamaki N., Kawamoto M., Takahashi N., et al: Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction : Comparison with stress thallium imaging. J Am Coll Cardiol22:1621-1627, 1993.
58.
Altehoefer C., Dahl J vom, Buell U., et al: Comparison of thallium 201 single-photon emission tomography after rest injection and fluorodeoxyglucose positron emission tomography for assessment of myocardial viability in patients with chronic coronary artery disease. Eur J Nucl Med21:37-45, 1994.
59.
Dreyfus GD, Duboc D., Blasco A., et al: Myocardial viability assessment in ischemic cardiomyopathy: Benefits of coronary revascularization. Ann Thorac Surg57:1402-1408, 1994.
60.
Go RT, Marwick TH, MacIntyre WJ, et al: A prospective comparison of rubidium-82 PET and thallium 201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med31 :1899-1905, 1990.
61.
Stewart RE, Schwaiger M., Molina E., et al: Comparison of rubidium-82 positron emission tomography and thallium 201 SPECT imaging for detection of coronary artery disease. Am J Cardiol67:1303-1310, 1991.
62.
Wackers FJTh : Planar, SPECT, PET: The quest to predict the unpredictable? J Nucl Med31:1906-1909, 1990.
63.
Perrone-Filardi P., Bacharach SL, Dilsizian V., et al: Regional left ventricular wall thickening: Relation to regional uptake of 18F-fluorodexyglucose and thallium 201 in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation86:1125-1137, 1992.
